UPC2 Method Development for Achiral Impurity Analysis

Importance of the Topic

Understanding impurity profiles in pharmaceuticals is critical for ensuring safety, efficacy, and regulatory compliance. Orthogonal analytical techniques such as UPC2 provide complementary selectivity to reversed-phase LC, aiding in the identification of unknown or late‐eluting impurities while reducing solvent use and analysis time.

Objectives and Study Overview

The study aimed to develop a systematic UPC2 method for achiral impurity analysis of metoclopramide and its related substances. Key goals included optimizing stationary phase selection, mobile phase composition, gradient slope, and additive effects to achieve high resolution and robust peak shapes across diverse functional groups.

Used Instrumentation

• ACQUITY UPC2 System with PDA (200–410 nm) and SQD MS (150–1200 Da, ESI+/-)
• ACQUITY UPC2 BEH 2-EP column (3.0 × 100 mm, 1.7 µm)
• Empower 3 Software for data acquisition and processing
• ACQUITY SQD Mass Spectrometer for peak tracking and specificity

Methodology

A resolution solution containing metoclopramide and eight related impurities (0.1% w/w) was prepared. Initial screening compared four stationary phases and four modifiers (MeOH, MeOH + 0.5% formic acid, MeOH + 2 g/L ammonium formate, MeOH + 0.5% triethylamine) under a gradient of 5→30% B over 5 min (hold 1 min). Further experiments varied gradient slope (6, 12, 35 min) and mixed MeOH with ACN (50:50 to 100:0) to assess elution strength. Additive concentrations were adjusted, including combined use of ammonium formate and formic acid, to refine peak shape across amine, hydroxyl, ester, and acid functionalities.

Main Results and Discussion

• Column Screening: BEH 2-EP delivered optimal peak shape and resolution. Other phases showed selectivity issues (e.g., split peaks on CSH Fluoro-Phenyl).
• Gradient Slope: Extending run time had minimal effect on resolution except for specific peak pairs.
• Modifier Composition: Blending ACN into MeOH expanded separation space and improved resolution of late-eluting analytes.
• Additive Effects: Combining 1 g/L ammonium formate with 3% formic acid yielded balanced peak shapes across all impurities.
• Specificity Assessment: Final method resolved known and unknown impurities in both control and degraded metoclopramide samples.

Benefits and Practical Applications

The optimized UPC2 approach offers rapid, high-resolution separations with reduced organic solvent consumption and orthogonal selectivity. It supports impurity profiling during drug development, stability testing, and quality control, facilitating regulatory compliance and decision‐making.

Future Trends and Opportunities

Further exploration of stationary phase–solute interactions will inform automated method development workflows. Integration with advanced MS detection and AI‐driven optimization algorithms may accelerate impurity identification and streamline regulatory submissions.

Conclusion

A systematic UPC2 method for achiral impurity analysis of metoclopramide has been established by optimizing column type, mobile phase composition, gradient conditions, and additives. The protocol delivers robust resolution, specificity, and peak integrity suitable for pharmaceutical impurity profiling.

References

1. Jones MD et al. Analysis of Organic Light Emitting Diode Materials by UltraPerformance Convergence Chromatography Coupled with Mass Spectrometry (UPC2/MS). Waters Application Note. 2012.
2. Jones MD et al. Impurity Profiling Using UPC2/MS. Waters Application Note. 2013.
3. West C, Lesellier E. A unified classification of stationary phases for packed column supercritical fluid chromatography. J Chromatogr A. 2008;1191(1-2):21-39.
4. West C, Khater S, Lesellier E. Characterization and use of hydrophilic interaction liquid chromatography type stationary phases in supercritical fluid chromatography. J Chromatogr A. 2012;1250:182-95.
5. Lesellier E. Retention mechanisms in super/subcritical fluid chromatography on packed columns. J Chromatogr A. 2009;1216(10):1881-90.
6. Zou W, Dorsey JG, Chester TL. Modifier effects on column efficiency in packed-column supercritical fluid chromatography. Anal Chem. 2000;72(15):3620-6.